As coronavaccine rollout nears, many concerns are raised in hard-hit Latin America stripes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stripes.com Daily Mail and Mail on Sunday newspapers.
MEXICO CITY
In Latin America, a region hard hit by pandemic, poverty and flawed healthcare systems, many experts fear that large-scale coronavirus immunization campaigns could prove a logistical nightmare, even as vaccinations are set to begin.
Home to 8.4% of the global population, Latin America and the Caribbean account for 30% of the world’s 1.6 million COVID-19 deaths and 19% of the 76 million COVID-19 infections, according to data from Johns Hopkins University and the World Bank.
Mexico and Chile plan to start inoculating health workers by month’s end with the vaccine developed by U.S.-based Pfizer Inc. and its German partner, BioNTech, which is already in use in the United States and Britain. Other Latin American countries are unveiling ambitious plans for large-scale immunization campaigns employing varying vaccines, most still in the testing stage and virtually all developed in the United States, Europe or Asia.
As vaccine rollout nears, many concerns raised in Latin America, hard hit by COVID-19 Patrick J. McDonnell, Kate Linthicum
In Latin America, a region hard hit by pandemic, poverty and flawed healthcare systems, many experts fear that large-scale coronavirus immunization campaigns could prove a logistical nightmare, even as vaccinations are set to begin.
Home to 8.4% of the global population, Latin America and the Caribbean account for 30% of the world’s 1.6 million COVID-19 deaths and 19% of the 76 million COVID-19 infections, according to data from Johns Hopkins University and the World Bank.
Mexico and Chile plan to start inoculating health workers by month s end with the vaccine developed by U.S.-based Pfizer Inc. and its German partner, BioNTech, which is already in use in the United States and Britain. Other Latin American countries are unveiling ambitious plans for large-scale immunization campaigns employing varying vaccines, most still in the testing st